Current Issue Sep-Oct 2026; Volume 6, Issue 5

ISSUE HIGHLIGHTS

Jejunal Mixed Adenoneuroendocrine Carcinoma (MANEC) With a Novel PTPRK-RSPO3 Fusion Initially Presenting as a Large Ovarian Mass: Diagnostic Challenges and Poor Prognosis
RAN WANG
 and 
JINPING LAI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 928-933 DOI: 10.21873/cdp.10594
Prognostic Impact of Recurrence Location in Locally Recurrent Rectal Cancer: A Single-Center Retrospective Study
SHO NAMBARA
, 
KOJI ANDO
, 
TETSURO KAWAZOE
, 
SHOTARO KOREHISA
, 
YASUO TSUDA
, 
TOMONORI NAKANOKO
, 
EIJI OKI
 and 
TOMOHARU YOSHIZUMI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 872-881 DOI: 10.21873/cdp.10588
Reduced HMGCR Expression in Clear Cell Renal Cell Carcinoma Is Associated With Poor Patient Prognosis
ETSUSHI AKITAYA
, 
YUZUKI NAKAMURA
, 
SHIHO KATO
, 
HINAYO KIKUTA
, 
TERUO ENDOH
, 
YASUHIRO KURAMITSU
 and 
YUJI TAKAHASHI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 864-871 DOI: 10.21873/cdp.10587
Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient Survival
SHIN-NOSUKE YAMASHITA
, 
YOSHIATSU TANAKA
, 
SHAJEDUL ISLAM
, 
TAKAO KITAGAWA
, 
KAZUHIRO TOKUDA
, 
DURGA PAUDEL
, 
SARITA GIRI
, 
TOHRU OHTA
, 
FUMIYA HARADA
, 
HIROKI NAGAYASU
 and 
YASUHIRO KURAMITSU
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 825-832 DOI: 10.21873/cdp.10584
Purchase access
Email Alerts

Table of contents Sep-Oct 2026; Volume 6, Issue 5

Research articles
Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient Survival
SHIN-NOSUKE YAMASHITA
, 
YOSHIATSU TANAKA
, 
SHAJEDUL ISLAM
, 
TAKAO KITAGAWA
, 
KAZUHIRO TOKUDA
, 
DURGA PAUDEL
, 
SARITA GIRI
, 
TOHRU OHTA
, 
FUMIYA HARADA
, 
HIROKI NAGAYASU
 and 
YASUHIRO KURAMITSU
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 825-832 DOI: 10.21873/cdp.10584
Transcriptomic Association Between Poliovirus Receptor (PVR/CD155) and Claudin Signaling Pathways in Colorectal Cancer
STEVEN LEHRER
 and 
PETER H. RHEINSTEIN
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 833-842 DOI: 10.21873/cdp.10585
Co-expression of the Mammaglobin (SCGB2A2) Gene With hsa-miR-184 and hsa-miR-190b Indicates Its Possible Role in Oncogenic Pathways in Breast Cancer
JUAN FELIPE ABELLA-DUQUE
, 
LILIANA LÓPEZ-KLEINE
, 
RAFAEL PARRA-MEDINA
, 
SANDRA RAMÍREZ-CLAVIJO
 and 
CÉSAR PAYÁN-GÓMEZ
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 843-863 DOI: 10.21873/cdp.10586
Reduced HMGCR Expression in Clear Cell Renal Cell Carcinoma Is Associated With Poor Patient Prognosis
ETSUSHI AKITAYA
, 
YUZUKI NAKAMURA
, 
SHIHO KATO
, 
HINAYO KIKUTA
, 
TERUO ENDOH
, 
YASUHIRO KURAMITSU
 and 
YUJI TAKAHASHI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 864-871 DOI: 10.21873/cdp.10587
Prognostic Impact of Recurrence Location in Locally Recurrent Rectal Cancer: A Single-Center Retrospective Study
SHO NAMBARA
, 
KOJI ANDO
, 
TETSURO KAWAZOE
, 
SHOTARO KOREHISA
, 
YASUO TSUDA
, 
TOMONORI NAKANOKO
, 
EIJI OKI
 and 
TOMOHARU YOSHIZUMI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 872-881 DOI: 10.21873/cdp.10588
Real-world Outcomes of First-line Platinum-based Chemotherapy in Patients Aged 80 Years or Older With Metastatic Urothelial Carcinoma
AKINORI MINATO
, 
KAZUMASA JOJIMA
, 
YUTO TSUBONUMA
, 
YUI MIZUSHIMA
, 
YOSHIHIRO SUGITA
, 
TAKUO MATSUKAWA
, 
IKKO TOMISAKI
 and 
EIJI KASHIWAGI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 882-889 DOI: 10.21873/cdp.10589
First-line Enfortumab Vedotin Plus Pembrolizumab in Platinum-ineligible Advanced Urothelial Carcinoma
GO KANEKO
, 
DAISUKE IGARASHI
 and 
SUGURU SHIROTAKE
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 890-899 DOI: 10.21873/cdp.10590
Preoperative Magnetic Resonance Imaging Findings of the Transition Zone Predict Incidental Prostate Cancer in HoLEP
TOSHIKI ITO
, 
YUSAKU HISAMATSU
, 
SHUHEI MIZUTANI
, 
TAKASHI KODAMA
, 
SHINYA WATANABE
, 
HIROYUKI AMANO
 and 
TERUO INAMOTO
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 900-908 DOI: 10.21873/cdp.10591
Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine
KIYOTSUGU IEDE
, 
TERUMASA YAMADA
, 
HIROTOSHI TAKAYAMA
, 
MASARU SASAKI
, 
TOMO ISHIDA
, 
MASAFUMI YAMASHITA
, 
YUKAKO MOKUTANI
, 
TSUKASA TANIDA
, 
JIN MATSUYAMA
, 
KEN NAKATA
 and 
SHUSEI TOMINAGA
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 909-917 DOI: 10.21873/cdp.10592
Two Cases of Uterine Small-cell Neuroendocrine Carcinoma With Somatostatin-receptor-type-2 (SSTR2) Expression and Minor Components of Endocervical Adenocarcinoma
MASAMICHI BAMBA
, 
TOMO NAMURA
, 
TOSHIKAZU KATO
, 
MASANORI SHIOHARA
, 
KENJI ISOGAWA
, 
MAO UEMURA
, 
SHIRO WAKINOUE
, 
HIROKO YOMO
, 
TETSUYA NAKAGAWA
, 
TETSUYA KATSUMORI
, 
RYOJI KUSHIMA
 and 
SUZUKO MORITANI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 918-927 DOI: 10.21873/cdp.10593
Jejunal Mixed Adenoneuroendocrine Carcinoma (MANEC) With a Novel PTPRK-RSPO3 Fusion Initially Presenting as a Large Ovarian Mass: Diagnostic Challenges and Poor Prognosis
RAN WANG
 and 
JINPING LAI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 928-933 DOI: 10.21873/cdp.10594
Immune Checkpoint Inhibitor Resistance in Rectal Adenocarcinoma Containing a Mismatch Repair Deficiency Component: A Case Report
KOHEI OKURA
, 
HARUKA TAKENAKA
, 
HIROSHI FUJITA
, 
NORIHISA HANADA
 and 
YOSHIHIRO KOMOHARA
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 934-941 DOI: 10.21873/cdp.10595
Malignant Myoepithelioma Arising from the Upper Arm With Brachial Plexus Involvement: A Rare Case
HAYATO TATSUMI
, 
TOSHIHIRO MATSUO
, 
TAKASHI NISHISAKA
, 
YUI HATTORI
, 
KOJI NISHIDA
, 
RYOUSUKE MATSUSHITA
, 
MASAHIRO YOSHIKAWA
, 
SATOSHI AKI
 and 
NOBUO ADACHI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 942-946 DOI: 10.21873/cdp.10596